OTIC Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa

News: OTIC Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa

Time: Friday, March 02, 2018 12:15

Intraday Maximum Change: $-0.475 - -8.52% Minutes After: 168

Latest Quote: 3.75 Change Since: $-2.3 - -61.33% Days Since: 138

Snapshot of company's key stats at the time of the event

Market Cap: 165,337,299 Shares Outstanding: 30,337,119 Float: 30,294,157

Day's Short Interest: 1,005,731 Short Ratio: 2.94%

Institutional Ownership: 32.9% Insider Ownership: 0%

OTIC - Otonomy Inc.

Sector: Healthcare - Industry: Biotechnology

Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear.